COVID-19: Vaccines and Therapeutics
In a study of over 7,000 adults hospitalized with COVID-19 symptoms, unvaccinated patients with prior SARS-CoV-2 infection were five times more likely to have laboratory-confirmed COVID-19 than were patients fully vaccinated against COVID-19 and no previous infection, the Centers for Disease…
Pediatricians join the front lines of COVID-19 vaccination plans as eligibility expands to children 5 to 11 years old.
Connecticut Children’s is sharing information to help parents prepare their children for the COVID-19 vaccine, once authorized for ages 5-11.
As a Centers for Disease Control and Prevention advisory committee prepares to consider expanding COVID-19 vaccine eligibility to children aged 5-11, the AHA, American Academy of Pediatrics and Children’s Hospital Association will webcast a panel discussion Nov. 8 at 2 p.m. ET on how pediatricians…
Please join the American Hospital Association, the American Academy of Pediatrics and the Children’s Hospital Association as pediatricians and hospital leaders discuss how doctors can work with parents to build trust in the safety and efficacy of COVID-19 vaccines for children, and offer key…
In a study comparing 6.4 million COVID-19 vaccine recipients with 4.6 million demographically similar unvaccinated persons, recipients of the Pfizer, Moderna or Janssen vaccines had lower non-COVID-19 mortality risk than did the unvaccinated comparison groups, the Centers for Disease Control and…
The Equal Employment Opportunity Commission posted updated and expanded technical assistance related to the COVID-19 pandemic, addressing questions about religious objections to employer COVID-19 vaccine requirements and how they interact with federal Equal Employment Opportunity laws.
In a letter to Sens. AHA expresses support for the Student Assisted Vaccination Effort Act (S. 2114).
Moderna released topline results from its ongoing phase 2/3 clinical trial of its COVID-19 vaccine for children age 6 through 11, revealing a strong antibody response against SARS-CoV-2.
The Centers for Medicare & Medicaid Services released Medicare Part B billing codes and payment allowances for reporting and administering single booster doses of the Moderna and Johnson & Johnson COVID-19 vaccines to eligible adults as authorized Oct. 22 by the Food and Drug Administration…